Sprint Bioscience’s collaborators at Nanyang Technological University in Singapore, have under the management of Sprint Bioscience’s co-founder Professor Pär Nordlund, published an article on fragment based drug discovery of tankyrase inhibitors; http://pubs.acs.org/doi/pdf/10.1021/jm400211f
